<html><head><style>div {border : red solid 0.5px}</style><style>span {border : blue dotted 0.5px}</style></head><body><div left="51.02" right="117.2" top="760.96"><span x0="51.02" y0="760.96" x1="117.2" style="x0: 51.02; x1: 56.58; y0: 760.96; y1: 770.96; width: 5.56; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">33. We need </span><span x0="118.12" y0="760.96" x1="564.15" style="x0: 118.12; x1: 122.19; y0: 760.96; y1: 770.96; width: 4.07; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Black;">to make sure there are sufficient raw materials and intermediate inputs to rapidly provide critical medical supplies at a global scale in a pandemic </span><span x0="332.89" y0="748.16" x1="564.16" style="x0: 332.89; x1: 338.08; y0: 748.16; y1: 758.16; width: 5.19; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">and that there is a large enough margin of error to accommodate multiple negative shocks, such as some supplies proving unusable or only one vaccine candidate with particular specialized adjuvant requirements proving successful in clinical trials.</span></div><div left="72.28" right="172.02" top="696.96"><span x0="72.28" y0="696.96" x1="172.02" style="x0: 72.28; x1: 77.47; y0: 696.96; y1: 706.96; width: 5.19; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">a. Doing so will also </span><span x0="172.94" y0="696.96" x1="425.65" style="x0: 172.94; x1: 177.01; y0: 696.96; y1: 706.96; width: 4.07; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Black;">reduce the short-term trade-offs that nations face </span><span x0="426.62" y0="696.96" x1="563.9" style="x0: 426.62; x1: 432.73; y0: 696.96; y1: 706.96; width: 6.11; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">between meeting immediate domestic needs and the global good, which all nations eventually benefit from. </span></div><div left="72.28" right="127.75" top="658.56"><span x0="72.28" y0="658.56" x1="127.75" style="x0: 72.28; x1: 78.39; y0: 658.56; y1: 668.56; width: 6.11; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">b. Ensuring </span><span x0="127.05" y0="658.56" x1="564.22" style="x0: 127.05; x1: 133.35; y0: 658.56; y1: 668.56; width: 6.3; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Black;">broader geographical diversification of manufacturing capacity would help develop resilience in supply chains in a crisis</span><span x0="205.79" y0="645.76" x1="564.07" style="x0: 205.79; x1: 208.57; y0: 645.76; y1: 655.76; width: 2.78; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">, and avoid the huge trust deficit seen in COVID-19 among countries dependent on unpredictable global arrangements.</span></div><div left="86.46" right="564.01" top="607.36"><span x0="86.46" y0="607.36" x1="564.01" style="x0: 86.46; x1: 88.86; y0: 607.36; y1: 617.36; width: 2.4; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">i. This could begin with a broader distribution of fill-and-finish facilities, while building up more advanced capabilities for biomanufacturing in the longer term. </span></div><div left="86.46" right="561.27" top="568.96"><span x0="86.46" y0="568.96" x1="561.27" style="x0: 86.46; x1: 88.86; y0: 568.96; y1: 578.96; width: 2.4; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">ii. We will however have to ensure that regional supply chains continue to work as part of a global system:</span></div><div left="100.63" right="564.11" top="543.36"><span x0="100.63" y0="543.36" x1="564.11" style="x0: 100.63; x1: 106.19; y0: 543.36; y1: 553.36; width: 5.56; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">1. The scale required for manufacturing means that individual regions will find it difficult to comprehensively cover all the possible platforms needed for responding to a future pandemic.</span></div><div left="100.64" right="409.99" top="504.96"><span x0="100.64" y0="504.96" x1="409.99" style="x0: 100.64; x1: 106.2; y0: 504.96; y1: 514.96; width: 5.56; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">2. Regional supply chains can still be vulnerable to localized shocks.</span></div><div left="86.46" right="564.04" top="479.36"><span x0="86.46" y0="479.36" x1="564.04" style="x0: 86.46; x1: 88.86; y0: 479.36; y1: 489.36; width: 2.4; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">iii. The need for greater diversification and resilience of supply chains also extends to PPE and other critical medical supplies</span><span x0="176.2" y0="470.94" x1="182.79" style="x0: 176.2; x1: 179.44; y0: 470.94; y1: 476.77; width: 3.24; font-size: 5.83; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">23</span><span x0="182.9" y0="466.56" x1="188.46" style="x0: 182.9; x1: 185.68; y0: 466.56; y1: 476.56; width: 2.78; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">. </span></div><div left="72.28" right="564.08" top="440.56"><span x0="72.28" y0="440.56" x1="564.08" style="x0: 72.28; x1: 77.1; y0: 440.56; y1: 450.56; width: 4.82; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">c. The remarkable progress achieved in research, manufacturing and market launch for vaccines has to be extended to diagnostics and therapeutics.</span></div><div left="51.02" right="145.21" top="401.56"><span x0="51.02" y0="401.56" x1="145.21" style="x0: 51.02; x1: 56.58; y0: 401.56; y1: 411.56; width: 5.56; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">34. We also need a </span><span x0="145.38" y0="401.56" x1="564.03" style="x0: 145.38; x1: 150.01; y0: 401.56; y1: 411.56; width: 4.63; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Black;">substantially larger network of sustainably-financed, ever-warm manufacturing capacity </span><span x0="72.27" y0="388.56" x1="379.59" style="x0: 72.27; x1: 75.79; y0: 388.56; y1: 398.56; width: 3.52; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">that can be repurposed in a pandemic to target specific pathogens.</span></div><div left="72.27" right="564.04" top="362.56"><span x0="72.27" y0="362.56" x1="564.04" style="x0: 72.27; x1: 77.46; y0: 362.56; y1: 372.56; width: 5.19; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">a. Multi-modal manufacturing capacity (mRNA, protein, and virus-based vaccines and therapeutics) can rapidly ramp up production of pandemic-specific medical countermeasures when needed.</span></div><div left="72.27" right="564.07" top="323.56"><span x0="72.27" y0="323.56" x1="564.07" style="x0: 72.27; x1: 78.38; y0: 323.56; y1: 333.56; width: 6.11; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">b. At-risk financing is needed for manufacturing of multiple prototype pathogen vaccine/diagnostic/therapeutic candidates before outbreaks. </span></div><div left="72.27" right="564.04" top="284.56"><span x0="72.27" y0="284.56" x1="564.04" style="x0: 72.27; x1: 77.09; y0: 284.56; y1: 294.56; width: 4.82; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">c. Dual-use purposes should be sought for such capacity, which could contribute to controlling endemic diseases and improving health outcomes during the inter-pandemic years. This can also improve the value proposition for such investments. </span></div><div left="72.27" right="564.09" top="232.56"><span x0="72.27" y0="232.56" x1="564.09" style="x0: 72.27; x1: 78.38; y0: 232.56; y1: 242.56; width: 6.11; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">d. Production capacities in different regions would render the system more resilient and contribute to a more equitable global distribution of scarce supplies</span><span x0="299.22" y0="223.94" x1="305.69" style="x0: 299.22; x1: 302.46; y0: 223.94; y1: 229.77; width: 3.24; font-size: 5.83; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">24</span><span x0="305.78" y0="219.56" x1="308.56" style="x0: 305.78; x1: 308.56; y0: 219.56; y1: 229.56; width: 2.78; font-size: 10.0; fill: [0.137, 0.123, 0.126]; font-family: WXJFMZ+AvenirLTStd-Roman;">.</span></div></body></html>